Parkinson’s disease affects 100,000 Australians, second only to dementia when it comes to neurological disease cases. Chances are you or someone you know will be affected by the disease, so it’s important to stay informed and be aware of the relevant forms of help available.
An Australian global clinical trial led by Epworth Assoc. Professor Miles Prince has seen a breakthrough drug being added to the Pharmaceutical Benefits Scheme (PBS).
The cells come from an unfertilized egg and were injected at 14 sites in the patient’s brain, with the hope that they would boost levels of the neurotransmitter dopamine.
Deep brain stimulation has been used for many years for treating essential tremors and other symptoms of Parkinson’s disease. Earlier this year, Epworth Richmond implanted a DBS device on its first patient, who travelled from Western Australia to have the surgery. We look at what deep brain stimulation involves and how the first patient fared from it.